Meyka AI API is live for developers.Start building.
Advertisement
Pulse Biosciences, Inc.

Pulse Biosciences, Inc. (PLSE) Stock Overview

Explore Pulse Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

PLSENASDAQ
HealthcareMedical - Instruments & Supplies
$25.33
$1.61(5.98%)
U.S. Market opens in 53h 7m
Advertisement

Pulse Biosciences, Inc. (PLSE)

Meyka AI Score

Z

Key Financials

Market Cap1.8B
P/E Ratio-22.72
EPS (TTM)$-1.10
ROE-0.87%
Fundamental Analysis

AI Price Forecasts

1 Month$27.04
3 Months$12.15
1 Year Target$24.36

PLSE Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Pulse Biosciences, Inc. (PLSE) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 53.75, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $24.36.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -22.72 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-5.98%
5-Day Change
3.60%
1-Month Change
35.82%
3-Month Change
36.33%
6-Month Change
90.88%
Year-to-Date (YTD) Change
84.49%
1-Year Change
55.21%
3-Year Change
310.53%
5-Year Change
36.84%
All-Time (Max) Change
507.43%

Contact Information

510 906 4600
3957 Point Eden Way, Miami, CA, 94545

Company Facts

75 Employees
IPO DateMay 18, 2016
CountryUS
Actively Trading

Frequently Asked Questions